Campo MS - Search Results

1

Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization.

Kirnbauer R, Chandrachud LM, O'Neil BW, Wagner ER, Grindlay GJ, Armstrong A, McGarvie GM, Schiller JT, Lowy DR, Campo MS. Kirnbauer R, et al. Among authors: campo ms. Virology. 1996 May 1;219(1):37-44. doi: 10.1006/viro.1996.0220. Virology. 1996. PMID: 8623552 Free article.

2

Studies on vaccination against papillomaviruses: prophylactic and therapeutic vaccination with recombinant structural proteins.

Jarrett WF, Smith KT, O'Neil BW, Gaukroger JM, Chandrachud LM, Grindlay GJ, McGarvie GM, Campo MS. Jarrett WF, et al. Among authors: campo ms. Virology. 1991 Sep;184(1):33-42. doi: 10.1016/0042-6822(91)90819-w. Virology. 1991. PMID: 1651594

3

Humoral immune response to the E7 protein of bovine papillomavirus type 4 and identification of B-cell epitopes.

Chandrachud LM, O'Neil BW, Jarrett WF, Grindlay GJ, McGarvie GM, Campo MS. Chandrachud LM, et al. Among authors: campo ms. Virology. 1994 Apr;200(1):98-104. doi: 10.1006/viro.1994.1167. Virology. 1994. PMID: 7510442

4

T cell responses to BPV-4 E7 during infection and mapping of T cell epitopes.

McGarvie GM, Grindlay GJ, Chandrachud LM, O'Neil BW, Jarrett WF, Campo MS. McGarvie GM, et al. Among authors: campo ms. Virology. 1995 Jan 10;206(1):504-10. doi: 10.1016/s0042-6822(95)80066-2. Virology. 1995. PMID: 7530395 Free article.

5

Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4.

Chandrachud LM, Grindlay GJ, McGarvie GM, O'Neil BW, Wagner ER, Jarrett WF, Campo MS. Chandrachud LM, et al. Among authors: campo ms. Virology. 1995 Aug 1;211(1):204-8. doi: 10.1006/viro.1995.1392. Virology. 1995. PMID: 7544045 Free article.

6

Prophylactic and therapeutic vaccination against a mucosal papillomavirus.

Campo MS, Grindlay GJ, O'Neil BW, Chandrachud LM, McGarvie GM, Jarrett WF. Campo MS, et al. J Gen Virol. 1993 Jun;74 ( Pt 6):945-53. doi: 10.1099/0022-1317-74-6-945. J Gen Virol. 1993. PMID: 8389809

7

Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodies.

Gaukroger JM, Chandrachud LM, O'Neil BW, Grindlay GJ, Knowles G, Campo MS. Gaukroger JM, et al. Among authors: campo ms. J Gen Virol. 1996 Jul;77 ( Pt 7):1577-83. doi: 10.1099/0022-1317-77-7-1577. J Gen Virol. 1996. PMID: 8758002

8

A peptide encoding a B-cell epitope from the N-terminus of the capsid protein L2 of bovine papillomavirus-4 prevents disease.

Campo MS, O'Neil BW, Grindlay GJ, Curtis F, Knowles G, Chandrachud L. Campo MS, et al. Virology. 1997 Aug 4;234(2):261-6. doi: 10.1006/viro.1997.8649. Virology. 1997. PMID: 9268157 Free article.

9

Epithelial specific transcriptional regulation of the bovine papillomavirus 4 promoter by E2.

Morgan IM, Grindlay GJ, Campo MS. Morgan IM, et al. Among authors: campo ms. J Gen Virol. 1998 Mar;79 ( Pt 3):501-8. doi: 10.1099/0022-1317-79-3-501. J Gen Virol. 1998. PMID: 9519828

10

The bovine papillomavirus type 4 long control region contains an epithelial specific enhancer.

Morgan IM, Grindlay GJ, Campo MS. Morgan IM, et al. Among authors: campo ms. J Gen Virol. 1999 Jan;80 ( Pt 1):23-27. doi: 10.1099/0022-1317-80-1-23. J Gen Virol. 1999. PMID: 9934679

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters